Breadcrumb Home investors investor resources Investor Resources Quick Explore Corporate Governance Shareholding Pattern Investor contact Year 2026-20272025-20262024-20252023-20242022-20232021-20222020-20212019-20202018-20192017-2018 Apply Cipla launches ‘ViraGen’ a polymerase chain reaction (RT-PCR) test 20th May 2021 Allotment of 26,338 equity shares under ESOS 2013-A 19th May 2021 Intimation of Appointment of Robert Stewart as Independent Director 14th May 2021 Grant of stock options and employee stock appreciation rights 14th May 2021 Re-appointment of Statutory Auditor 14th May 2021 Outcome of Board Meeting – 14th May 2021 14th May 2021 Cipla enters into a Licensing Agreement with Lilly to Expand Access to COVID-19 Treatment in India 10th May 2021 Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19 05th May 2021 Incorporation of a wholly-owned subsidiary by GoApptiv Private Limited 03rd May 2021 Revision of partnership interest in ABCD Technologies LLP 30th Apr 2021 + BSE and NSE Quotes by TradingView The displayed data is not in real time and may have streaming delays.
